Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
Authors: D Patoulias, A Boulmpou, E Teperikidis, A Katsimardou, F Siskos, A Tranidou, A Nikolaidis, D Mouselimis, M Doumas, C E Papadopoulos, V Vassilikos